Retrieve available abstracts of 50 articles: HTML format
Single Articles
June 2025
BATES KR, Jones W, Liggett MR, Zaza NN, et al Complications Following Open Versus Minimally Invasive Resection of Gastric
Adenocarcinoma.
J Surg Oncol. 2025;131:1302-1312. PubMedAbstract available
PRELA O, Caveney B, Strawderman M, Linehan D, et al A Reassessment of the Clinical Utility of (68)Ga-DOTATATE PET/CT in Patients With
Gastroenteropancreatic Neuroendocrine Tumors.
J Surg Oncol. 2025;131:1336-1342. PubMedAbstract available
PETTIGREW MF, Kumar P, Nahi SL, Reznik SI, et al CT Scans Understage Lymph Nodes in Gastric and Gastroesophageal Adenocarcinoma.
J Surg Oncol. 2025;131:1571-1579. PubMedAbstract available
May 2025
ZHOU X, Jiang Y, Xu H, Lin S, et al Modified Frailty Index Predicts Prognosis in Patients With Gastric Cancer After
Gastrectomy: A Systematic Review and Meta-Analysis.
J Surg Oncol. 2025 May 14. doi: 10.1002/jso.28136. PubMedAbstract available
March 2025
WANG YC, Liao YJ, Lin WT, Liao SC, et al Assessment of Endoscopic Ultrasound for Predicting Preoperative T Staging in
Patients With Gastric Adenocarcinoma.
J Surg Oncol. 2025;131:411-416. PubMedAbstract available
LI MX, Lopez-Aguiar AG, Poultsides G, Rocha F, et al Preoperative Glycosylated Hemoglobin A1C Impacts Long-Term Outcomes Following
Curative-Intent Resection of Nonfunctional Gastroenteropancreatic Neuroendocrine
Tumors.
J Surg Oncol. 2025;131:473-480. PubMedAbstract available
KELLY NJ, Shafique N, Tortorello GN, Vargas G, et al Total Gastrectomy for Gastric Malignancy: Trends Over 15 Years in Major
Morbidity, Mortality, and Patient Selection From The National Surgical Quality
Improvement Program.
J Surg Oncol. 2025;131:624-629. PubMedAbstract available
February 2025
SONG Y, Chen E, Chiang YJ, Yao JC, et al Classification of Gastric Neuroendocrine Tumors and Associations With Survival.
J Surg Oncol. 2025;131:204-211. PubMedAbstract available
January 2025
DOBRZHANSKYI O, Gaskill CE, Kizub D, Kondratskyi Y, et al Utilization of Staging Laparoscopy for Patients With Gastric Cancer in Ukraine.
J Surg Oncol. 2025 Jan 19. doi: 10.1002/jso.28095. PubMedAbstract available
December 2024
ZHU A, Kosyachkova E, Tiano T, Coburn NG, et al Letter to the Editor: Reporting of Core Outcomes in Gastric Cancer Surgical
Trials Over the Past 25 Years (Systematic Review).
J Surg Oncol. 2024 Dec 19. doi: 10.1002/jso.28057. PubMed
GUL S, Alberto M, Annika K, Pratschke J, et al Emerging Treatment Modalities for Gastric Cancer With Macroscopic Peritoneal
Metastases: A Systematic Review.
J Surg Oncol. 2024 Dec 10. doi: 10.1002/jso.27987. PubMedAbstract available
HU Q, Shi J, Yang X FLOT x8 for Gastric Cancer: Progress or Premature Optimism?
J Surg Oncol. 2024 Dec 3. doi: 10.1002/jso.28028. PubMed
VITELLO DJ, Zaza NN, Bates KR, Janczewski LM, et al Current National Treatment Trends for Gastric Adenocarcinoma in the United
States.
J Surg Oncol. 2024;130:1563-1572. PubMedAbstract available
KHIABANY A, Dermanis AA, Liew MS, Ong KR, et al A Systematic Review of Surgical and Pathological Outcomes in Patients With a CDH1
Mutation Undergoing Total Gastrectomy.
J Surg Oncol. 2024;130:1539-1550. PubMedAbstract available
November 2024
YIBREHU B, Mohammed TO, Murthy S, Aderibigbe AS, et al Gastric Cancer at a Nigerian Tertiary Referral Center: Experiences With
Establishing an Institutional Cancer Registry.
J Surg Oncol. 2024 Nov 18. doi: 10.1002/jso.27993. PubMedAbstract available
JI ZH, Zhao QD, Li Y The Effects of HIPEC on Survival of Gastric Cancer Patients With Peritoneal
Metastasis.
J Surg Oncol. 2024 Nov 17. doi: 10.1002/jso.27877. PubMedAbstract available
October 2024
KLINGBEIL KD, Eng IK, Dube P, Dillon DL, et al CT Imaging as a Single Modality for Clinical Staging of Gastric Cancer in Limited
Resource Centers: A Retrospective Pilot Study.
J Surg Oncol. 2024 Oct 15. doi: 10.1002/jso.27857. PubMedAbstract available
RENCUZOGULLARI A, Karahan SN, Selcukbiricik F, Lacin S, et al The New Era of Total Neoadjuvant FLOT Therapy for Locally Advanced, Resectable
Gastric Cancer: A Propensity-Matched Comparison With Standard Perioperative
Therapy.
J Surg Oncol. 2024 Oct 13. doi: 10.1002/jso.27934. PubMedAbstract available
AJAY PS, Mavani PT, Sok CP, Goyal S, et al Comparison of treatment strategies based on clinical and pathological nodal
status in resectable gastric adenocarcinoma.
J Surg Oncol. 2024;130:1078-1091. PubMedAbstract available
September 2024
ARARUNA GF, Ribeiro HSC, Torres SM, Diniz AL, et al Impact of Minimally Invasive Surgery on Early and Late Outcomes of Patients With
Gastric Cancer Treated Using Neoadjuvant Chemotherapy.
J Surg Oncol. 2024 Sep 19. doi: 10.1002/jso.27904. PubMedAbstract available
RAMOS MFKP, Gusmao JS, Pereira MA, Ribeiro-Junior U, et al Textbook outcome for evaluating the surgical quality of gastrectomy.
J Surg Oncol. 2024;130:769-775. PubMedAbstract available
RAMOS MFKP, Pereira MA, Santos SM, Dias AR, et al Gastrectomies for the treatment of gastric cancer in a reference cancer center
present better pathological results and survival compared to non-specialized
hospitals.
J Surg Oncol. 2024;130:750-756. PubMedAbstract available
PEREIRA MA, Ramos MFKP, Dias AR, Yagi OK, et al Adjuvant chemotherapy versus preoperative chemotherapy for gastric cancer treated
with curative-intent resection: A propensity score-matched analysis.
J Surg Oncol. 2024;130:724-733. PubMedAbstract available
DA SILVA GOMES S, Oliveira CS, Furtado TA, Melo LM, et al Recurrence of fusocellular subtype GIST with SDHB mutation: A case of SDHB-loss
and therapeutic challenges.
J Surg Oncol. 2024;130:741-742. PubMedAbstract available
LIMA CAC, Martins MR, Dos Santos RL, da Silva LM, et al Soluble levels of 4-1BB (CD137) and OX40 (CD134) are associated with cancer
progression in gastric adenocarcinoma.
J Surg Oncol. 2024;130:734-740. PubMedAbstract available
August 2024
KITAI T, Yamanaka K Conversion surgery for gastric cancer with PM.
J Surg Oncol. 2024 Aug 19. doi: 10.1002/jso.27794. PubMedAbstract available
July 2024
TAKAHASHI H, Nakauchi M, Hiotis S, Datta R, et al Neoadjuvant chemotherapy for resectable gastric cancer is associated with better
outcomes than neoadjuvant chemoradiation.
J Surg Oncol. 2024 Jul 31. doi: 10.1002/jso.27761. PubMedAbstract available
CASS SH, Williams LA, Rajaram R, Hirata Y, et al Patient-reported outcome measures in surgical patients with upper
gastrointestinal cancers: A qualitative interview study.
J Surg Oncol. 2024;130:117-124. PubMedAbstract available
June 2024
DA SILVA LM, Martins MR, Dos Santos RL, Da Silva JPA, et al Evaluation of soluble co-inhibitors and co-stimulators levels of the immune
response in gastric cancer.
J Surg Oncol. 2024 Jun 30. doi: 10.1002/jso.27747. PubMedAbstract available
SOUZA WP, Pereira MA, Cardili L, Zilberstein B, et al Evaluation of the endoscopic cure criteria in patients undergoing surgery for
early gastric cancer.
J Surg Oncol. 2024 Jun 27. doi: 10.1002/jso.27745. PubMedAbstract available
JANCZEWSKI LM, Buchheit J, Jacobs RC, Vitello D, et al Utilization and survival outcomes of neoadjuvant chemotherapy for early-stage
gastric cancer.
J Surg Oncol. 2024 Jun 17. doi: 10.1002/jso.27732. PubMedAbstract available
May 2024
JANCZEWSKI LM, Bentrem DJ, Chawla A Response to comment on: "Comparison of perioperative and histopathologic outcomes
among neoadjuvant treatment strategies for locoregional gastric cancer".
J Surg Oncol. 2024 May 27. doi: 10.1002/jso.27678. PubMed
DA COSTA WL JR,, Tan MC, Camp ER, Thrift AP, et al Patient- and system-level factors associated with racial/ethnic disparities in
the delivery of guideline-concordant therapy among US patients with gastric
cancer.
J Surg Oncol. 2024 May 16. doi: 10.1002/jso.27683. PubMedAbstract available
CORSO G, Davis JL, Strong VE Points to consider regarding prophylactic total gastrectomy in germline CDH1
variant carriers.
J Surg Oncol. 2024;129:1082-1088. PubMedAbstract available
April 2024
LI C, Qu M, Ye Y, Zhu F, et al Letter to the Editor: Comment on: "Comparison of perioperative and
histopathologic outcomes among neoadjuvant treatment strategies for locoregional
gastric cancer".
J Surg Oncol. 2024 Apr 29. doi: 10.1002/jso.27667. PubMed
DIAS AR, Pereira MA, Ramos MFKP, de Oliveira RJ, et al Robotic versus laparoscopic gastrectomy for gastric cancer: A Western propensity
score matched analysis.
J Surg Oncol. 2024 Apr 17. doi: 10.1002/jso.27651. PubMedAbstract available
March 2024
NAQVI A, Matias N, Al-Khaffaf B Reporting of core outcomes in gastric cancer surgery trials over the past 25
years (systematic review).
J Surg Oncol. 2024 Mar 6. doi: 10.1002/jso.27613. PubMedAbstract available
KIM JY, Love M, Woo Y, Campos B, et al Pilot study of a telehealth intervention for personalized self-management for
eating symptoms after gastroesophageal cancer surgery.
J Surg Oncol. 2024;129:728-733. PubMedAbstract available
February 2024
LILLEY EJ, Lu P, Robinson K, Griffith H, et al High symptom burden in patients undergoing gastrectomy for cancer.
J Surg Oncol. 2024;129:228-232. PubMedAbstract available
January 2024
HONDO N, Yamamoto Y, Nakabe T, Otsubo T, et al Short-term outcomes of laparoscopic and robotic distal gastrectomy for gastric
cancer: Real-world evidence from a large-scale inpatient database in Japan.
J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27575. PubMedAbstract available
VAN DER WIELEN N, Brenkman H, Seesing M, Daams F, et al Minimally invasive versus open gastrectomy for gastric cancer. A pooled analysis
of two European randomized controlled trials.
J Surg Oncol. 2024 Jan 4. doi: 10.1002/jso.27578. PubMedAbstract available
SESTITO M, Pratt H, Schmidt C, Thomay A, et al Recent advances for treatment of upper gastrointestinal malignancy.
J Surg Oncol. 2024;129:48-62. PubMedAbstract available
December 2023
CASPERS IA, Slagter AE, Lind P, Sikorska K, et al The impact of sex on treatment and outcome in relation to histological subtype in
patients with resectable gastric cancer: Results from the randomized CRITICS
trial.
J Surg Oncol. 2023 Dec 10. doi: 10.1002/jso.27554. PubMedAbstract available
KARALIS JD, Ju MR, Feig R, Estrella R, et al Intensifying supportive care is associated with improved survival in gastric
cancer patients with malignant ascites.
J Surg Oncol. 2023 Dec 8. doi: 10.1002/jso.27556. PubMedAbstract available
November 2023
JANCZEWSKI LM, Logan CD, Vitello DJ, Buchheit JT, et al Comparison of perioperative and histopathologic outcomes among neoadjuvant
treatment strategies for locoregional gastric cancer.
J Surg Oncol. 2023 Nov 20. doi: 10.1002/jso.27521. PubMedAbstract available
October 2023
MAVANI PT, Ajay PS, Goyal S, Shah MM, et al Reply to: Striking a balance: Deciphering the dilemma of treatment equivalence in
cardia gastric cancer.
J Surg Oncol. 2023 Oct 17. doi: 10.1002/jso.27483. PubMed
LOUAFI MO, Lahnaoui O, Benkabbou A, Majbar MA, et al Striking a balance: Deciphering the dilemma of treatment equivalence in cardia
gastric cancer.
J Surg Oncol. 2023 Oct 16. doi: 10.1002/jso.27452. PubMed
June 2023
JANCZEWSKI LM, Shah D, Wells A, Bentrem DJ, et al The inaccuracies of gastric adenocarcinoma clinical staging and its predictive
factors.
J Surg Oncol. 2023;127:1116-1124. PubMedAbstract available
April 2023
AJAY PS, Sok CP, Goyal S, Switchenko JM, et al Impact of nodal status in determining multimodal treatment strategies in
non-cardia gastric cancer.
J Surg Oncol. 2023 Apr 28. doi: 10.1002/jso.27297. PubMedAbstract available
AJAY PS, NeMoyer R, Goyal S, Switchenko JM, et al Does non-metastatic gastric cancer of the cardia warrant a different treatment
strategy?
J Surg Oncol. 2023 Apr 10. doi: 10.1002/jso.27276. PubMedAbstract available